ReviewFrontiers in pharmacology2026
Oxidative stress mediated oleanolic acid therapeutic potential in rheumatoid arthritis: focus on the mechanisms.
Review in Frontiers in pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Rheumatoid arthritis (RA) is a chronic systemic autoimmune disease of unknown etiology. Several signaling pathways associated with oxidative stress, such as Nrf2, NOX and NF-κB, have been implicated in the pathogenesis of RA. Promoted reactive oxygen species cause the damage of lipids, nucleic acid and proteins, leading to RA. Given the evidence of the damage caused by oxidative stress to rheumatoid arthritis, the use of antioxidants has become a comprehensive approach for treating the disease. The natural antioxidant oleanolic acid (OA) modulates several signaling pathways connected to redox imbalance, thereby mitigating oxidative injury. Medical research has confirmed that OA has significant therapeutic potential in a variety of diseases through anti-oxidation, anti-inflammation, anti-apoptosis, and participates in the regulation of glucose and lipid metabolism. This article reviews the signaling pathways and antioxidant activity of OA in the pathogenesis of RA, as well as the research progress in the prevention and treatment of RA in recent years, to identify therapeutic targets and new antioxidant treatment methods for RA.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.